Network News

On the trail of contacts: European Research Council funds pioneering MitoContact project to investigate communication between mitochondria and other cell components Kai Johnsson, Director at the Max Planck Institute for Medical Research, has been awarded a Synergy Grant by the European Research Council (ERC). In the funded project MitoContact, he will work with two scientists from Switzerland to […]

European Research Council awards prestigious funding for complex research projects Scientists at Heidelberg University are to receive two prestigious ERC Synergy Grants awarded by the European Research Council (ERC) for groundbreaking research projects that will be carried out jointly by several teams. Prof. Dr Dr Amir Abdollahi is coordinating a tri-national collaboration with colleagues in […]

Ependymomas, brain tumors that occur particularly in young children, are especially difficult to treat and more than half of the children affected have an increased risk of relapse. As part of an international consortium, the Hopp Children’s Cancer Center Heidelberg (KiTZ), the German Cancer Research Center (DKFZ), the Medical Faculty of Heidelberg University (MFHD) and […]

Cambridge, UK, and Lausanne, Switzerland, 05 November 2025: SPT Labtech, a global leader in the design and development of laboratory automation and liquid handling solutions, and Alithea Genomics, a pioneer in the field of large-scale RNA sequencing and transcriptomics, today announced a collaboration to provide an automated solution for single-cell transcriptomics.  The collaboration integrates Alithea […]

EMBL researchers were awarded a BII foundation grant to support Model-MI – an in vitro model that mimics the maternal-fetal interface Pregnancy is a period of both excitement and concern for the healthy development of the foetus and the well-being of the expectant mother. During the ~40 weeks of gestation, many external factors constitute a danger for […]

Ladenburg, Germany, 23 October 2025 – Heidelberg Pharma AG (FSE: HPHA), a clinical-stage biotech company developing innovative Antibody Drug Conjugates (ADCs), today announced that HDP-101 (INN: pamlectabart tismanitin), the Company’s lead Amanitin-based ADC candidate, has been granted Fast Track Designation by the US Food and Drug Administration (FDA). This designation was supported by nonclinical data as […]

Vienna, Austria – October 22, 2025 – GalaTek GmbH, a leading innovator in laboratory automation technologies, and a:head bio AG, a pioneering biotech company specializing in human brain organoid research, today announced a strategic collaboration aimed at advancing the automation of brain organoid workflows. The partnership aims to integrate GalaTek’s advanced robotics and software platforms with […]

Heidelberg, Germany, October 22, 2025 – It’s all about a sustainable, smarter energy future: Clean Tech Innovation Day & Solar TAP Industry Day showed that this can only be achieved with a shared mission and vision. More than 70 participants from science, industry, and start-ups took the opportunity at the Heidelberg Congress Center to exchange […]

Sanofi’s Wayrilz recommended for EU approval by the CHMP to treat immune thrombocytopenia Paris, October 17, 2025. The European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion recommending the approval of Wayrilz (rilzabrutinib) as a new treatment for immune thrombocytopenia (ITP) in adult patients who are refractory to other […]